Trials / Completed
CompletedNCT01919749
A Pilot Study Utilizing Proteomic and Genomic Profiling for Patients With Metastatic Breast Cancer
A Pilot Study Utilizing Proteomic and Genomic Profiling by Reverse Phase Protein Microarray (RPMA), IHC Analysis, RNA Seq, and Exome Sequencing of Patients' Tumors to Find Potential Targets and Select Treatments for Patients With Metastatic Breast Cancer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Translational Drug Development · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will use proteomic and genomic profiling to analyze tumor tissue to see if treatment selected by this analysis will benefit patients.
Detailed description
To examine the impact of targeted therapy for breast cancer based upon proteomic and genomic profiling using RPMA, IHC analysis, RNA-Seq, and Exome sequencing on PFS and GMI.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | treated recommended | Treatment will be recommended after reviewing the profiling analysis |
Timeline
- Start date
- 2013-08-01
- Primary completion
- 2016-08-01
- Completion
- 2016-10-01
- First posted
- 2013-08-09
- Last updated
- 2023-03-28
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01919749. Inclusion in this directory is not an endorsement.